Immunometabolic Signature and Tauopathy Markers in Blood Cells of Progressive Supranuclear Palsy

PSP displays a systemic inflammatory shift of the peripheral immunity, which may justify a metabolic reprogramming of the blood leukocytes. Consistently, the NRF2/HO-1 pathway, a master regulator of inflammatory and metabolic response, was activated. PBMCs also engulf tau proteins, especially p-tau, in a way inverse to the disease severity, allowing for a peripheral tracking of tauopathy in patients. Immunometabolic targets may, therefore, gain relevance to PSP in biomarker or therapeutic purposes. © 2024 International Parkinson and Movement Disorder Society.

Authors

Institutions

Publication Details

Journal
Movement Disorders
Published
2024-09-16
DOI
https://doi.org/10.1002/mds.30009
Citations
6
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
1.96

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunometabolic Signature and Tauopathy Markers in Blood Cells of Progressive Supranuclear Palsy

Massimo Marano, Patrizia Longone, Valentina Nesci, Cristiana Valle et al.
6 citations
Movement Disorders
Alzheimer's disease research and treatments
1.96
article

Immunometabolic Signature and Tauopathy Markers in Blood Cells of Progressive Supranuclear Palsy

Massimo Marano, Patrizia Longone, Valentina Nesci, Cristiana Valle, Davide Mascioli, Valerio Chiurchiù, Daniela Maftei, Clara Simonetta, Mariangela Pierantozzi, Alberto Ferri, Henri Zenuni, Tommaso Schirinzi, Jacopo Bissacco, Marco Rosina, Roberta Bovenzi, Alessandro Stefani, Nicola Biagio Mercuri, Federica Veltri
article en
6 citations

Abstract

PSP displays a systemic inflammatory shift of the peripheral immunity, which may justify a metabolic reprogramming of the blood leukocytes. Consistently, the NRF2/HO-1 pathway, a master regulator of inflammatory and metabolic response, was activated. PBMCs also engulf tau proteins, especially p-tau, in a way inverse to the disease severity, allowing for a peripheral tracking of tauopathy in patients. Immunometabolic targets may, therefore, gain relevance to PSP in biomarker or therapeutic purposes. © 2024 International Parkinson and Movement Disorder Society.

Movement DisordersVol. 39(12)
University of Rome Tor Vergata (IT), Università Campus Bio-Medico (IT), Istituto di Farmacologia Traslazionale (IT), Policlinico Tor Vergata (IT), Campus Bio Medico University Hospital (IT), Fondazione Santa Lucia (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), National Research Council (IT)
European Commission, Ministero della Salute, Ministero dell'Università e della Ricerca
Openalex Percentile: Top 13%
Alzheimer's disease research and treatments
1.96
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.